Logo image of INVX

INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

USA - NYSE:INVX - US4576511079 - Common Stock

20.07 USD
-0.61 (-2.95%)
Last: 10/31/2025, 5:05:01 PM
20.07 USD
0 (0%)
After Hours: 10/31/2025, 5:05:01 PM
Fundamental Rating

7

Taking everything into account, INVX scores 7 out of 10 in our fundamental rating. INVX was compared to 60 industry peers in the Energy Equipment & Services industry. INVX has an excellent financial health rating, but there are some minor concerns on its profitability. INVX is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make INVX suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year INVX was profitable.
In the past year INVX had a positive cash flow from operations.
In multiple years INVX reported negative net income over the last 5 years.
In multiple years INVX reported negative operating cash flow during the last 5 years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

INVX's Return On Assets of 11.77% is amongst the best of the industry. INVX outperforms 95.00% of its industry peers.
INVX has a better Return On Equity (14.51%) than 78.33% of its industry peers.
With a decent Return On Invested Capital value of 7.20%, INVX is doing good in the industry, outperforming 63.33% of the companies in the same industry.
Industry RankSector Rank
ROA 11.77%
ROE 14.51%
ROIC 7.2%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 16.66%, INVX belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
INVX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 11.37%, INVX is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
In the last couple of years the Operating Margin of INVX has grown nicely.
With a decent Gross Margin value of 32.96%, INVX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of INVX has grown nicely.
Industry RankSector Rank
OM 11.37%
PM (TTM) 16.66%
GM 32.96%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INVX is destroying value.
INVX has more shares outstanding than it did 1 year ago.
INVX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, INVX has a worse debt to assets ratio.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 5.44 indicates that INVX is not in any danger for bankruptcy at the moment.
INVX's Altman-Z score of 5.44 is amongst the best of the industry. INVX outperforms 95.00% of its industry peers.
The Debt to FCF ratio of INVX is 0.23, which is an excellent value as it means it would take INVX, only 0.23 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of INVX (0.23) is better than 95.00% of its industry peers.
INVX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, INVX belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.23
Altman-Z 5.44
ROIC/WACC0.82
WACC8.75%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 4.60 indicates that INVX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.60, INVX belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
INVX has a Quick Ratio of 2.69. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.69, INVX belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.6
Quick Ratio 2.69
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

9

3. Growth

3.1 Past

INVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 204.76%, which is quite impressive.
INVX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 123.23% yearly.
INVX shows a strong growth in Revenue. In the last year, the Revenue has grown by 41.65%.
Measured over the past years, INVX shows a quite strong growth in Revenue. The Revenue has been growing by 9.76% on average per year.
EPS 1Y (TTM)204.76%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%130%
Revenue 1Y (TTM)41.65%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%86.33%

3.2 Future

Based on estimates for the next years, INVX will show a very strong growth in Earnings Per Share. The EPS will grow by 148.21% on average per year.
The Revenue is expected to grow by 41.05% on average over the next years. This is a very strong growth
EPS Next Y493%
EPS Next 2Y148.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year93.68%
Revenue Next 2Y41.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.41 indicates a quite expensive valuation of INVX.
Compared to the rest of the industry, the Price/Earnings ratio of INVX indicates a slightly more expensive valuation: INVX is more expensive than 60.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of INVX to the average of the S&P500 Index (26.19), we can say INVX is valued inline with the index average.
With a Price/Forward Earnings ratio of 14.19, INVX is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INVX indicates a somewhat cheap valuation: INVX is cheaper than 65.00% of the companies listed in the same industry.
INVX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.50.
Industry RankSector Rank
PE 30.41
Fwd PE 14.19
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INVX indicates a slightly more expensive valuation: INVX is more expensive than 76.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, INVX is valued cheaply inside the industry as 88.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.66
EV/EBITDA 9.73
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of INVX may justify a higher PE ratio.
A more expensive valuation may be justified as INVX's earnings are expected to grow with 148.21% in the coming years.
PEG (NY)0.06
PEG (5Y)0.25
EPS Next 2Y148.21%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

INVX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INNOVEX INTERNATIONAL INC

NYSE:INVX (10/31/2025, 5:05:01 PM)

After market: 20.07 0 (0%)

20.07

-0.61 (-2.95%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners47.97%
Inst Owner Change0.05%
Ins Owners1.52%
Ins Owner Change3.11%
Market Cap1.38B
Revenue(TTM)867.15M
Net Income(TTM)144.48M
Analysts77.78
Price Target18.7 (-6.83%)
Short Float %N/A
Short Ratio9.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP51.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.38%
Min EPS beat(2)-24.08%
Max EPS beat(2)-22.68%
EPS beat(4)1
Avg EPS beat(4)-40.73%
Min EPS beat(4)-165.36%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-164.95%
EPS beat(12)3
Avg EPS beat(12)-83.38%
EPS beat(16)3
Avg EPS beat(16)-90.25%
Revenue beat(2)1
Avg Revenue beat(2)1.36%
Min Revenue beat(2)-4.42%
Max Revenue beat(2)7.14%
Revenue beat(4)3
Avg Revenue beat(4)5.8%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)10.25%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.02%
EPS NY rev (1m)0%
EPS NY rev (3m)12.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.28%
Valuation
Industry RankSector Rank
PE 30.41
Fwd PE 14.19
P/S 1.59
P/FCF 7.66
P/OCF 7
P/B 1.39
P/tB 1.78
EV/EBITDA 9.73
EPS(TTM)0.66
EY3.29%
EPS(NY)1.41
Fwd EY7.05%
FCF(TTM)2.62
FCFY13.05%
OCF(TTM)2.87
OCFY14.28%
SpS12.61
BVpS14.47
TBVpS11.29
PEG (NY)0.06
PEG (5Y)0.25
Graham Number14.66
Profitability
Industry RankSector Rank
ROA 11.77%
ROE 14.51%
ROCE 9.12%
ROIC 7.2%
ROICexc 7.69%
ROICexgc 9.81%
OM 11.37%
PM (TTM) 16.66%
GM 32.96%
FCFM 20.77%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y74.94%
ROICexc growth 3YN/A
ROICexc growth 5Y70.29%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.23
Debt/EBITDA 0.24
Cap/Depr 38.12%
Cap/Sales 1.96%
Interest Coverage 250
Cash Conversion 137.61%
Profit Quality 124.67%
Current Ratio 4.6
Quick Ratio 2.69
Altman-Z 5.44
F-Score6
WACC8.75%
ROIC/WACC0.82
Cap/Depr(3y)71.76%
Cap/Depr(5y)56.98%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)204.76%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%130%
EPS Next Y493%
EPS Next 2Y148.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)41.65%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%86.33%
Revenue Next Year93.68%
Revenue Next 2Y41.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y81.5%
EBIT growth 3YN/A
EBIT growth 5Y80.9%
EBIT Next Year99.1%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y301.81%
FCF growth 3Y41.07%
FCF growth 5Y90.29%
OCF growth 1Y438.74%
OCF growth 3Y34.47%
OCF growth 5Y44.76%

INNOVEX INTERNATIONAL INC / INVX FAQ

Can you provide the ChartMill fundamental rating for INNOVEX INTERNATIONAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVX.


What is the valuation status of INNOVEX INTERNATIONAL INC (INVX) stock?

ChartMill assigns a valuation rating of 6 / 10 to INNOVEX INTERNATIONAL INC (INVX). This can be considered as Fairly Valued.


What is the profitability of INVX stock?

INNOVEX INTERNATIONAL INC (INVX) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for INVX stock?

The Price/Earnings (PE) ratio for INNOVEX INTERNATIONAL INC (INVX) is 30.41 and the Price/Book (PB) ratio is 1.39.


What is the expected EPS growth for INNOVEX INTERNATIONAL INC (INVX) stock?

The Earnings per Share (EPS) of INNOVEX INTERNATIONAL INC (INVX) is expected to grow by 493% in the next year.